HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Global demethylation in loss of imprinting subtype of Wilms tumor.

Abstract
Epigenetic abnormalities at the IGF2/H19 locus play a key role in the onset of Wilms tumor. These tumors can be classified into three molecular subtypes depending on the events occurring at this locus: loss of imprinting (LOI), loss of heterozygosity (LOH), or retention of imprinting (ROI). As IGF2 LOI is a consequence of aberrant methylation, we hypothesized that this subtype of Wilms tumors might display global abnormalities of methylation. We therefore analyzed the methylation status of satellite DNA, as a surrogate for global methylation in 50 Wilms tumor patients. Satellite methylation was quantified by a methylation-sensitive quantitative PCR. We confirmed hypomethylation of both satellite α (Sat α) and satellite 2 (Sat 2) DNA in Wilms tumor samples compared with normal kidney. In addition, we found that LOI tumors, unlike ROI or LOH ones, showed concordant hypomethylation of both Sat α and Sat 2 DNA. This would suggest that the LOI subtype of Wilms tumor, which unlike other subtypes results from an epimutation, has a global deregulation of methylation mechanisms.
AuthorsJackie L Ludgate, Gwenn Le Mée, Ryuji Fukuzawa, Euan J Rodger, Robert J Weeks, Anthony E Reeve, Ian M Morison
JournalGenes, chromosomes & cancer (Genes Chromosomes Cancer) Vol. 52 Issue 2 Pg. 174-84 (Feb 2013) ISSN: 1098-2264 [Electronic] United States
PMID23074036 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Wiley Periodicals, Inc.
Chemical References
  • DNA, Satellite
  • Insulin-Like Growth Factor II
Topics
  • Blotting, Southern
  • DNA Methylation
  • DNA, Satellite (genetics)
  • Genomic Imprinting
  • Genomic Instability
  • Humans
  • Insulin-Like Growth Factor II (genetics)
  • Polymerase Chain Reaction
  • Wilms Tumor (classification, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: